Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
09/2009
09/02/2009EP1557466B1 Tumor antigen protein and utilization thereof
09/02/2009EP1466925B1 Antibodies against fibroblast growth factor 23
09/02/2009EP1368380B1 Stabilisation of heavy chain Camelid antibodies with potassium salts
09/02/2009EP1317479B1 Methods and compositions for diseases associated with amyloidosis
09/02/2009EP1282443B1 Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy
09/02/2009EP1085908B1 Recombinant immunotoxin directed against the hiv-1 gp120 envelope glycoprotein
09/02/2009EP0892643B2 Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith
09/02/2009CN101522718A Anti-idiotypic antibody which neutralizes the inhibitory activity of an inhibitory antibody directed against the c1 domain of factor viii
09/02/2009CN101522717A Antibodies to erbb2
09/02/2009CN101522716A High affinity human antibodies to human IL-4 receptor
09/02/2009CN101522715A Monoclonal antibody to soluble LOX-1
09/02/2009CN101522714A Ige-retargeting, function-altering molecules (ERFAM) for treatment of allergic diseases
09/02/2009CN101522713A Variable region sequences of IL-31 monoclonal antibodies and methods of use
09/02/2009CN101522712A Novel multivalent immunoglobulins
09/02/2009CN101519650A Gobrocypris rarus vitellogenin monoclonal antibody and application thereof
09/02/2009CN101519448A Epididymal protease inhibitor protein monoclonal antibody and application thereof
09/02/2009CN101519447A Anti-rabbit hemorrhagic disease virus VP60 albumen monoclonal antibody
09/02/2009CN101518653A Methods of treatment using anti-erbb antibody-maytansinoid conjugates
09/02/2009CN101518648A Soluble receptor BR43x2 and methods of using
09/02/2009CN100535013C Selective targeting of tumor vasculature using antibody molecules
09/02/2009CN100535012C Polyclonal antibody of colibacillus, prepartioon method and appication
09/02/2009CN100535011C Coli flagellum polyclonal antibody, and its preparing method and use
09/02/2009CN100535010C Coli obtrite holosomatic polyclonal antibody, and its preparing method and use
09/02/2009CN100535009C Coli somatic polyclonal antibody, and its preparing method and use
09/02/2009CN100535008C Coli common pili polyclonal antibody, and its preparing method and use
09/02/2009CN100535004C Iron regulating protein-2 (IRP-2) as a diagnostic for neurodegenerative disease
09/01/2009US7582778 Podophyllotoxin
09/01/2009US7582736 Prostate cancer specific internalizing human antibodies
09/01/2009US7582735 use of peptides derived from IgE sequences for allergic desensitization; culturing
09/01/2009US7582734 natural ligand for the orphan G-Protein Coupled Receptor (GPCR) ChemerinR and uses thereof in diagnosis and immuno therapy of a disease; monoclonal antibody; chemiattractant proteins; useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of GPCR signaling
09/01/2009US7582733 Modified immunoglobulin for use in diagnosis, prevention and treatment of alzheimer's disease; immunotherapy
09/01/2009US7582730 an iron-regulated protein found in Neisseria gonorrhoeae or Neisseria meningitidis outer membranes; immunizing a host against gonococcal and meningococcal diseases, such as gonorrhea, meningitis
09/01/2009US7582728 Microwave-assisted peptide synthesis
09/01/2009US7582726 cancer therapy utilizing novel vascular endothelial cell growth factor receptor antagonists; immunoglobulin like domain from kinase domain receptor; nucleic acid encoding prolactin receptor antagonizing domain, a VEGF ligand and a cytokine; cell based assay;
09/01/2009US7582725 Agents, which inhibit apoptosis in cells that are involved in wound healing
09/01/2009US7582478 Cleaved serum response factor in cardiac diagnosis and therapy
09/01/2009US7582451 Carotene synthase gene and uses therefor
09/01/2009US7582448 nucleotide sequences coding protein of urogenital system for identifying modulators for treatment of cell proliferative and metastatic disorders
09/01/2009US7582445 Anti-interferon-α antibodies
09/01/2009US7582443 Method for the detection and measurement of Hapten-conjugated biological binding entities by western and dot-blot using anti-hapten antibodies
09/01/2009US7582440 Imaging, diagnosis and treatment of disease
09/01/2009US7582439 Detecting the presence/absence of a complex of a Bim molecule (a novel member of the Bcl-2 family) and an antibody specific for a specific amino acid sequence;modulating physiological cell death or survival and/or modulating cell cycle entry; antiapoptosis; anticarcinogenic agents; autoimmune diseases
09/01/2009US7582437 Adaptor protein that binds to mammalian toll-like receptor 3, and gene thereof
09/01/2009US7582416 Ligand for G-protein coupled receptor FPRL2 and uses thereof
09/01/2009US7582300 Modulation of gamma delta T cells to regulate airway hyperresponsiveness
09/01/2009US7582299 Cripto-specific antibodies
09/01/2009US7582298 High affinity antibodies to human IL-6 receptor
09/01/2009US7582297 Methods of treating respiratory conditions
09/01/2009US7582296 Anti-idiotypic antibodies against factor VIII inhibitor and uses thereof
09/01/2009US7582294 Medicament for treating prostate diseases
09/01/2009US7582288 Methods of targeting multiple cytokines
09/01/2009US7581953 Interactive dental restorative network
09/01/2009CA2327434C Dna immunization against chlamydia infection
09/01/2009CA2294514C Method for identification of cellular protein antigens and presence of antibodies to specific cellular protein antigens in serum
09/01/2009CA2281491C Zcytor7 cytokine receptor
08/2009
08/27/2009WO2009105681A1 Neutralization of staphylococcal and streptococcal toxins
08/27/2009WO2009105548A2 Methods for treating diabetes
08/27/2009WO2009105269A1 Antibodies directed to angiopoietin-1 and angiopoietin-2 and use thereof
08/27/2009WO2009104963A1 Methods and compositions of sphingolipid for preventing and treating microbial infections
08/27/2009WO2009104736A1 Antibody having affinity for amyloid plaque in tissue, and pharmaceutical composition comprising the same
08/27/2009WO2009104100A2 Antibody combinations, and methods of making and using same
08/27/2009WO2009103969A1 Synthetic scfv analogue to the 6313/g2 (anti angiotensin ii type 1 receptor) monoclonal antibody variable regions
08/27/2009WO2009103862A2 Method for detecting mitotic cells
08/27/2009WO2009103796A1 Use of substances for sensitization of tumor cells to radiation and/or chemotherapy
08/27/2009WO2009103538A1 Procedure for the generation of a high producer cell line for the expression of a recombinant anti-cd34 antibody
08/27/2009WO2009103243A1 CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS POLYMERASE PAc-PB1n COMPLEX AND USES THEREOF
08/27/2009WO2009103160A1 Treatment and prevention of dry age-related macular degeneration by activating cd36
08/27/2009WO2009103157A1 Mfap4 as a marker for regulatory cells and anti-cancer cells
08/27/2009WO2009103113A1 HUMANIZED ANTI-C5aR ANTIBODIES
08/27/2009WO2009083009A3 Monoclonal antibodies against cd32b
08/27/2009WO2009077479A3 Altering high-density lipoprotein levels through carboxylesterase 1 modulation
08/27/2009WO2009071860A3 G immunoglobulin used against anthrax toxins
08/27/2009WO2009043922A3 Extracellular targets for alzheimer's disease
08/27/2009WO2009009086A3 Methods and compositions for inactivating alpha 1,6 fucosyltransferase (fut 8) gene expression
08/27/2009WO2008140477A3 Hybrid immunoglobulins with moving parts
08/27/2009WO2007143231A3 Methods of treating pain and inflammation in neuronal tissue using il-31 antagonists
08/27/2009US20090217423 Ce43-67b insecticidal cotton
08/27/2009US20090217406 Plant cells and plants with increased tolerance to environmental stress
08/27/2009US20090217401 Human Monoclonal Antibodies To Programmed Death 1(PD-1) And Methods For Treating Cancer Using Anti-PD-1 Antibodies Alone or in Combination with Other Immunotherapeutics
08/27/2009US20090217392 Anti- integrin antibodies, compositions, methods and uses
08/27/2009US20090217391 T1r3 a novel taste receptor
08/27/2009US20090215995 isolated nucleic acids encoding B7-related polypeptides, including BSL3, which modulate cells that are important for immune and inflammatory responses, such as T-cells
08/27/2009US20090215994 Novel Centromeric Protein Shugoshin
08/27/2009US20090215993 Mycophenolic acid immunogens and antibodies
08/27/2009US20090215992 Engineered multivalent and multispecific binding proteins; treatment of acute and chronic inflammatory, cancer
08/27/2009US20090215991 increased affinity for Fc gamma RIIc; enhanced efficacy
08/27/2009US20090215984 Conversion of apoptotic proteins
08/27/2009US20090215711 Novel compositions and methods in cancer
08/27/2009US20090215691 NOGO Receptor Antagonists
08/27/2009US20090215679 Disease-associated proteins
08/27/2009US20090215672 Cys-Rich, Cell Surface Glycoproteins
08/27/2009US20090215197 containing first domain having hypervariable loop structure at binding site to target substance, and second domain having no hypervariable loop structure at binding site; kits
08/27/2009US20090215195 Set1 proteins and uses thereof
08/27/2009US20090215175 Modulation of the poliovirus receptor function
08/27/2009US20090215092 Antibodies for Anthrax
08/27/2009US20090215087 Toxoplasma gondii Oocyst Protein
08/27/2009US20090215071 Methods of targeting baff
08/27/2009US20090215070 Highly Sensitive Immunoassays and Antibodies for Detection of Blood Factor VIII
08/27/2009US20090215063 Phosphospecific PAK antibodies and diagnostic kits
08/27/2009US20090215042 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis